Drug Approval | March 18, 2023
Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
The plant is scheduled to come on stream in September 2024
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Subscribe To Our Newsletter & Stay Updated
